Dialysis patients run the risk of impaired antioxidative defense and increa
sed free radicals (FR) production. The study was made in order to compare F
R-related parameters in ten patients treated with erythropoietin (EPO+) and
ten patients not subject to this treatment (EPO-). All patients showed sta
ble hemoglobin levels at > 95 g/L. FR-related parameters were monitored dur
ing hemodialysis (HD) using a polysulfon (PS) or a hemophan (H) membrane fo
r 12 of them (6 EPO+ a 6 EPO-). The EPO- group was found to have a higher a
ctivity of superoxide dismutase (SOD, 1160 + 218 vs; 882 + 125 IU/gHb, p<0.
01) and a higher SOD/glutathione peroxidase (GSHPx) ratio compared with EPO
+ (30.5 +/- 7.1 vs; 21.2 + 4.8, p<0.01). A fetal of 35 healthy volunteers w
ere also examined. When compared with controls EPO- showed higher SOD (p<0.
001), lower GSHPx (p<0.05) and a higher SBD/GSHPx ratio (p<0.001). Thiobarb
ituric acid reacting substances in EPO+ and EPO- were comparable with the l
evels found in controls. HD using H as well as PS membranes was associated
with a decrease in erythrocyte glutathione levels (GSH after 30 minutes; al
so for H after HD). HD using H and PS membranes resulted in a decrease in t
he plasma antioxidant capacity (AOC). We can conclude that the intraerythro
cyte antioxidant conditions of EPO+ patients are similar to those found in
the general population and differ from those in EPO- exhibiting increased S
OD and the SOD/GSHPx ratio. HD using the H as well as the PS membrane is ac
companied by oxidative stress.